阻断剂-话题@MedSci

#阻断剂#

31篇内容 | 473人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1816443, encodeId=796e181644308, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Crit Care：急性呼吸窘迫综合征(ARDS)的COVID-19患者早期短疗程神经肌肉阻断剂的治疗效果, objectType=article, longId=727459, objectId=25c5e2745918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25c5e2745918, replyNumber=0, likeNumber=39, createdTime=2023-03-10, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25c5e2745918, moduleTitle=Crit Care：急性呼吸窘迫综合征(ARDS)的COVID-19患者早期短疗程神经肌肉阻断剂的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25c5e2745918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816442, encodeId=61451816442e0, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=JCEM：PD-1和CTLA-4阻断剂会增加甲状腺功能障碍的风险, objectType=article, longId=220894, objectId=3cc7220894b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cc7220894b1, replyNumber=0, likeNumber=43, createdTime=2022-05-08, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cc7220894b1, moduleTitle=JCEM：PD-1和CTLA-4阻断剂会增加甲状腺功能障碍的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cc7220894b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816441, encodeId=f514181644118, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=创新性SARS-CoV-2阻断剂可完全防止细胞感染, objectType=article, longId=204373, objectId=616f2043e3df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616f2043e3df, replyNumber=0, likeNumber=37, createdTime=2021-08-07, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616f2043e3df, moduleTitle=创新性SARS-CoV-2阻断剂可完全防止细胞感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616f2043e3df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816438, encodeId=2d0918164382f, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=JACC：神经体液阻断剂的停用对心衰患者的影响, objectType=article, longId=191020, objectId=fa6d191020ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa6d191020ff, replyNumber=0, likeNumber=51, createdTime=2020-07-12, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa6d191020ff, moduleTitle=JACC：神经体液阻断剂的停用对心衰患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa6d191020ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816439, encodeId=caa51816439ad, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Sci Rep：放疗局部前列腺癌男性中α阻断剂对复发影响的试验回顾分析 , objectType=article, longId=195461, objectId=44e119546127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44e119546127, replyNumber=0, likeNumber=34, createdTime=2021-04-30, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44e119546127, moduleTitle=Sci Rep：放疗局部前列腺癌男性中α阻断剂对复发影响的试验回顾分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44e119546127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816440, encodeId=b42118164405c, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, objectType=article, longId=197668, objectId=c43e19e6680f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43e19e6680f, replyNumber=0, likeNumber=41, createdTime=2021-06-16, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43e19e6680f, moduleTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43e19e6680f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816436, encodeId=7e3f18164366d, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=高血压评估容量负荷建议：推荐评估吃盐量，**RAAS阻断剂+利尿剂, objectType=article, longId=168523, objectId=50ba1685238b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50ba1685238b, replyNumber=0, likeNumber=25, createdTime=2020-01-26, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50ba1685238b, moduleTitle=高血压评估容量负荷建议：推荐评估吃盐量，**RAAS阻断剂+利尿剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50ba1685238b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816437, encodeId=4a4d181643e63, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, objectType=article, longId=179432, objectId=0a3e1e94321f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a3e1e94321f, replyNumber=0, likeNumber=38, createdTime=2020-02-10, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a3e1e94321f, moduleTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a3e1e94321f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816434, encodeId=55a5181643468, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Am J Kidney Dis：持续血透患者：两大常用β-阻断剂大PK, objectType=article, longId=150658, objectId=e80a15065895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e80a15065895, replyNumber=0, likeNumber=37, createdTime=2019-06-08, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e80a15065895, moduleTitle=Am J Kidney Dis：持续血透患者：两大常用β-阻断剂大PK, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e80a15065895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816435, encodeId=09d2181643592, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的, objectType=article, longId=156150, objectId=0066156150be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0066156150be, replyNumber=0, likeNumber=40, createdTime=2019-04-06, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0066156150be, moduleTitle=J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0066156150be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816433, encodeId=e5201816433c3, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Otolaryngol Head Neck Surg：单独口服抗组胺药或组合白三烯素阻断剂对过敏性鼻炎治疗的分析, objectType=article, longId=128061, objectId=044a1280619b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044a1280619b, replyNumber=0, likeNumber=42, createdTime=2018-10-20, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044a1280619b, moduleTitle=Otolaryngol Head Neck Surg：单独口服抗组胺药或组合白三烯素阻断剂对过敏性鼻炎治疗的分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044a1280619b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816431, encodeId=b2f01816431af, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Ann Oncol：使用β－肾上腺素受体阻断剂能显著改善的HER2阴性的晚期乳腺癌患者的无进展生存期, objectType=article, longId=111335, objectId=5da0111335c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5da0111335c2, replyNumber=0, likeNumber=39, createdTime=2017-09-29, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5da0111335c2, moduleTitle=Ann Oncol：使用β－肾上腺素受体阻断剂能显著改善的HER2阴性的晚期乳腺癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5da0111335c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816427, encodeId=4aad181642e8a, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Ann Surg：β-阻断剂对创伤性脑损伤的作用研究现状, objectType=article, longId=99262, objectId=11c19926241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11c19926241, replyNumber=0, likeNumber=37, createdTime=2017-06-08, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11c19926241, moduleTitle=Ann Surg：β-阻断剂对创伤性脑损伤的作用研究现状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11c19926241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816429, encodeId=8e8418164292f, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Eur Heart J：射血分数降低的心衰患者：ACEI、ARB或β-受体阻断剂剂量减少后果很严重, objectType=article, longId=107605, objectId=c36c10e60511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c36c10e60511, replyNumber=0, likeNumber=32, createdTime=2018-06-01, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c36c10e60511, moduleTitle=Eur Heart J：射血分数降低的心衰患者：ACEI、ARB或β-受体阻断剂剂量减少后果很严重, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c36c10e60511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816432, encodeId=e33418164322a, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Intern Med J：心脏选择性β受体阻断剂治疗COPD急性加重安全吗？, objectType=article, longId=117422, objectId=881011e422e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=881011e422e1, replyNumber=0, likeNumber=31, createdTime=2017-12-28, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=881011e422e1, moduleTitle=Intern Med J：心脏选择性β受体阻断剂治疗COPD急性加重安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=881011e422e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816425, encodeId=dd14181642541, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=JAHA：高血压患者β阻断剂的使用与左心房功能受损有关！, objectType=article, longId=88738, objectId=945188e38e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=945188e38e0, replyNumber=0, likeNumber=33, createdTime=2017-04-25, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=945188e38e0, moduleTitle=JAHA：高血压患者β阻断剂的使用与左心房功能受损有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=945188e38e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816426, encodeId=43d51816426a4, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Ann Surg：β阻断剂可以减少腹主动脉瘤术后死亡率, objectType=article, longId=98669, objectId=836598669f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=836598669f6, replyNumber=0, likeNumber=39, createdTime=2018-03-02, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=836598669f6, moduleTitle=Ann Surg：β阻断剂可以减少腹主动脉瘤术后死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=836598669f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816430, encodeId=6b3a181643007, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素受体阻断剂有望实现进一步开发！, objectType=article, longId=107984, objectId=1eaf10e984cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eaf10e984cb, replyNumber=0, likeNumber=31, createdTime=2018-07-02, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eaf10e984cb, moduleTitle=Diabetes Obes Metab：胰高血糖素受体阻断剂有望实现进一步开发！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eaf10e984cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816428, encodeId=b8361816428c0, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=Diabetes Obes Metab:β-受体阻断剂能否降低2型糖尿病合并冠心病患者的死亡率, objectType=article, longId=103759, objectId=0dc5103e5980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dc5103e5980, replyNumber=0, likeNumber=44, createdTime=2017-12-18, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dc5103e5980, moduleTitle=Diabetes Obes Metab:β-受体阻断剂能否降低2型糖尿病合并冠心病患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dc5103e5980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1816424, encodeId=8e751816424f0, content=<a href='/topic/show?id=08049e6803b' target=_blank style='color:#2F92EE;'>#阻断剂#</a>, objectTitle=BMJ：α-阻断剂更加有效地清除较大的肾结石, objectType=article, longId=83665, objectId=8c208366583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c208366583, replyNumber=0, likeNumber=51, createdTime=2017-07-28, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c208366583, moduleTitle=BMJ：α-阻断剂更加有效地清除较大的肾结石, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c208366583)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻断剂

2020-05-29

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Crit Care：急性呼吸窘迫综合征(ARDS)的COVID-19患者早期短疗程神经肌肉阻断剂的治疗效果

2023-03-10

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

JCEM：PD-1和CTLA-4阻断剂会增加甲状腺功能障碍的风险

2022-05-08

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

创新性SARS-CoV-2阻断剂可完全防止细胞感染

2021-08-07

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

JACC：神经体液阻断剂的停用对心衰患者的影响

2020-07-12

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Sci Rep：放疗局部前列腺癌男性中α阻断剂对复发影响的试验回顾分析

2021-04-30

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号

2021-06-16

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

高血压评估容量负荷建议：推荐评估吃盐量，**RAAS阻断剂+利尿剂

2020-01-26

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变

2020-02-10

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Am J Kidney Dis：持续血透患者：两大常用β-阻断剂大PK

2019-06-08

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的

2019-04-06

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Otolaryngol Head Neck Surg：单独口服抗组胺药或组合白三烯素阻断剂对过敏性鼻炎治疗的分析

2018-10-20

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Ann Oncol：使用β－肾上腺素受体阻断剂能显著改善的HER2阴性的晚期乳腺癌患者的无进展生存期

2017-09-29

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Ann Surg：β-阻断剂对创伤性脑损伤的作用研究现状

2017-06-08

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Eur Heart J：射血分数降低的心衰患者：ACEI、ARB或β-受体阻断剂剂量减少后果很严重

2018-06-01

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Intern Med J：心脏选择性β受体阻断剂治疗COPD急性加重安全吗？

2017-12-28

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

JAHA：高血压患者β阻断剂的使用与左心房功能受损有关！

2017-04-25

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Ann Surg：β阻断剂可以减少腹主动脉瘤术后死亡率

2018-03-02

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Diabetes Obes Metab：胰高血糖素受体阻断剂有望实现进一步开发！

2018-07-02

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

Diabetes Obes Metab:β-受体阻断剂能否降低2型糖尿病合并冠心病患者的死亡率

2017-12-18

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#阻断剂#

BMJ：α-阻断剂更加有效地清除较大的肾结石

2017-07-28

科室
- - 订阅+
  - 更多科室
工具
服务